Risk of adverse cardiovascular events based on common genetic variants in 8-year follow-up of the LIPIDOGEN2015 population using the polygenic risk score (PRS): study design and methodology.

Autor: Banach, Maciej^1,2,3,4 maciej.banach@iczmp.edu.pl, Fronczek, Martyna⁵, Osadnik, Tadeusz⁵, Gach, Agnieszka⁶, Strapagiel, Dominik⁷, Słomka, Marcin⁷, Lejawa, Mateusz⁵, Goc, Anna⁸, Boniewska-Bernacka, Ewa⁸, Pańczyszyn, Anna⁸, Lip, Gregory Y. H.^9,10, Mikhailidis, Dimitri P.¹¹, Toth, Peter P.^3,12, Penson, Peter E.^4,13, Jóźwiak, Jacek¹⁴

Publikováno v: Archives of Medical Science. Oct2024, Vol. 20 Issue 5, p1452-1460. 9p.

Predictive value of polygenic risk score for prostate cancer incidence and prognosis in the Han Chinese.

Autor: Hung, Sheng-Chun^1,2,3, Chang, Li-Wen^1,2,3, Hsiao, Tzu-Hung^4,5,6, Wei, Chia-Yi⁴, Wang, Shian-Shiang^1,3,7, Li, Jian-Ri^1,2,3,8, Chen, I-Chieh⁴ icchen@vghtc.gov.tw

Publikováno v: Scientific Reports. 9/3/2024, Vol. 14 Issue 1, p1-14. 14p.

An Integrative Migraine Polygenic Risk Score Is Associated with Age at Onset But Not Chronification.

Autor: Chase, Bruce A.^1,2 (AUTHOR) bchase@northshore.org, Frigerio, Roberta^2,3 (AUTHOR), Rubin, Susan^4,5 (AUTHOR), Franada, Tiffani⁴ (AUTHOR), Semenov, Irene^2,4 (AUTHOR), Meyers, Steven^2,4 (AUTHOR), Bergman-Bock, Stuart⁴ (AUTHOR), Mark, Angela^4,5 (AUTHOR), Freedom, Thomas^2,4 (AUTHOR), Marcus, Revital⁴ (AUTHOR), Dafer, Rima^4,6 (AUTHOR), Wei, Jun⁷ (AUTHOR), Zheng, Siqun L.⁷ (AUTHOR), Xu, Jianfeng⁷ (AUTHOR), Mulford, Ashley J.⁸ (AUTHOR), Sanders, Alan R.^8,9 (AUTHOR), Pham, Anna⁴ (AUTHOR), Epshteyn, Alexander¹ (AUTHOR), Maraganore, Demetrius^4,10 (AUTHOR), Markopoulou, Katerina^4,5 (AUTHOR)

Publikováno v: Journal of Clinical Medicine. Nov2024, Vol. 13 Issue 21, p6483. 16p.

Understanding the Biological Basis of Polygenic Risk Scores and Disparities in Prostate Cancer: A Comprehensive Genomic Analysis.

Autor: Zhang, Wensheng¹ (AUTHOR), Zhang, Kun^1,2 (AUTHOR) kzhang@xula.edu

Publikováno v: Cancer Informatics. 10/21/2024, p1-12. 12p.

Polygenic Risk Score (PRS) Combined with NGS Panel Testing Increases Accuracy in Hereditary Breast Cancer Risk Estimation.

Autor: Tsoulos, Nikolaos¹ (AUTHOR) ntsoulos@genekor.com, Papadopoulou, Eirini¹ (AUTHOR) eirinipapad@genekor.com, Agiannitopoulos, Konstantinos¹ (AUTHOR) kagiannitopoulos@genekor.com, Grigoriadis, Dimitrios¹ (AUTHOR) gtsaousis@genekor.com, Tsaousis, Georgios N.¹ (AUTHOR) d.bouzarelou@genekor.com, Bouzarelou, Dimitra¹ (AUTHOR) gnasioulas@genekor.com, Gogas, Helen² (AUTHOR) helgogas@gmail.com, Troupis, Theodore³ (AUTHOR) ttroupis@med.uoa.gr, Venizelos, Vassileios⁴ (AUTHOR) bennievenizelos@gmail.com, Fountzilas, Elena⁵ (AUTHOR) fountzila@oncogenome.gr, Theochari, Maria⁶ (AUTHOR) mtheochari@gmail.com, Ziogas, Dimitrios C.² (AUTHOR) ziogasdc@gmail.com, Giassas, Stylianos⁷ (AUTHOR) sgiassas@yahoo.com, Koumarianou, Anna⁸ (AUTHOR) akoumari@yahoo.com, Christopoulou, Athina⁹ (AUTHOR) athinachristo@hotmail.com, Busby, George¹⁰ (AUTHOR) george@allelica.com, Nasioulas, George¹ (AUTHOR), Markopoulos, Christos³ (AUTHOR) klinikimastou@yahoo.gr

Publikováno v: Diagnostics (2075-4418). Aug2024, Vol. 14 Issue 16, p1826. 12p.